These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 8452705

  • 41. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
    Meijer MJ, Mieremet-Ooms MA, van der Zon AM, van Duijn W, van Hogezand RA, Sier CF, Hommes DW, Lamers CB, Verspaget HW.
    Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
    [Abstract] [Full Text] [Related]

  • 42. Significance of diminished factor XIII in Crohn's disease.
    Chamouard P, Grunebaum L, Wiesel ML, Sibilia J, Coumaros G, Wittersheim C, Baumann R, Cazenave JP.
    Am J Gastroenterol; 1998 Apr; 93(4):610-4. PubMed ID: 9576457
    [Abstract] [Full Text] [Related]

  • 43. Increased serum bone sialoprotein concentrations in patients with Crohn's disease.
    Faust D, Menge F, Armbruster FP, Lembcke B, Stein J.
    Z Gastroenterol; 2003 Mar; 41(3):243-7. PubMed ID: 12664344
    [Abstract] [Full Text] [Related]

  • 44. Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.
    Husain N, Tokoro K, Popov JM, Naides SJ, Kwasny MJ, Buchman AL.
    J Clin Gastroenterol; 2013 Mar; 47(3):246-51. PubMed ID: 23269308
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T, May B, Pfisterer O, Müller KM, Brasch F.
    Hepatogastroenterology; 2002 Mar; 49(43):116-23. PubMed ID: 11941933
    [Abstract] [Full Text] [Related]

  • 47. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
    Kull K, Salupere R, Uibo R, Ots M, Salupere V.
    Hepatogastroenterology; 1998 Mar; 45(24):2132-7. PubMed ID: 9951879
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
    Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis IE, Kouroumalis EA.
    Am J Gastroenterol; 2001 Mar; 96(3):776-81. PubMed ID: 11280550
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Falchuk KR, Perrotto JL, Isselbacher KJ.
    N Engl J Med; 1975 Feb 20; 292(8):395-7. PubMed ID: 1110725
    [Abstract] [Full Text] [Related]

  • 53. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis.
    Zezos P, Papaioannou G, Nikolaidis N, Patsiaoura K, Vassiliadis T, Mpoumponaris A, Giouleme O, Evgenidis N.
    Med Sci Monit; 2009 Nov 20; 15(11):CR563-72. PubMed ID: 19865055
    [Abstract] [Full Text] [Related]

  • 54. [Sonography of chronic inflammatory bowel diseases--a prospective study].
    Worlicek H, Lutz H, Thoma B.
    Ultraschall Med; 1986 Dec 20; 7(6):275-80. PubMed ID: 3547638
    [Abstract] [Full Text] [Related]

  • 55. Abnormalities of fasting serum concentrations of peptide YY in the idiopathic inflammatory bowel diseases.
    Koch TR, Roddy DR, Go VL.
    Am J Gastroenterol; 1987 Apr 20; 82(4):321-6. PubMed ID: 3565336
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Serum angiotensin converting enzyme activity in Crohn's disease and ulcerative colitis.
    Letizia C, D'Ambrosio C, Agostini D, Corsi A, Boirivant M, Pallone F, Scavo D.
    Ital J Gastroenterol; 1993 Jan 20; 25(1):23-5. PubMed ID: 8381313
    [Abstract] [Full Text] [Related]

  • 58. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.
    Oruç N, Ozütemiz O, Osmanoğlu N, Ilter T.
    Turk J Gastroenterol; 2009 Mar 20; 20(1):9-12. PubMed ID: 19330729
    [Abstract] [Full Text] [Related]

  • 59. Serum lysozyme in inflammatory bowel disease.
    Dobbins JW, Binder HJ, Spiro HM, Finch SC.
    Gastroenterology; 1976 Mar 20; 70(3):469-71. PubMed ID: 1248707
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.